» Articles » PMID: 28640958

Recommendations for Revision of Chinese Diagnostic Criteria for Metabolic Syndrome: A Nationwide Study

Overview
Journal J Diabetes
Specialty Endocrinology
Date 2017 Jun 23
PMID 28640958
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diagnostic criteria for metabolic syndrome (MS) proposed by the Chinese Diabetes Society (CDS) may have limitations because an additional 2-h postprandial plasma glucose (2-h PPG) test is required to diagnose hyperglycemia. The aim of this study was to revise the CDS-MS criteria by removing the 2-h PPG test and determining the optimal fasting plasma glucose (FPG) cut-off for a diagnosis of hyperglycemia in the Chinese population.

Methods: The study population was from the 2007-08 China Diabetes and Metabolic Disorders Study. The optimal FPG diagnostic cut-off value was determined using receiver operating characteristic curves. Hyperglycemia defined using CDS-MS criteria was the end-point. Agreement between different diagnostic methods was assessed using κ values.

Results: The study enrolled 46 239 participants (mean age 44.95 years). The optimal diagnostic cut-off for FPG was found to be 5.62 mmol/L, which showed a sensitivity of 66.92%, a specificity of 89.09%, and an area under the curve of 0.848. Using this diagnostic criterion, the standardized prevalence of MS was similar to that using the CDS-MS criteria (18.26% vs 17.89%, respectively), with both values being lower than those obtained using conventional international criteria (20.64-26.67%). Compared with the CDS-MS criteria, the recommended FPG cut-off showed better agreement (κ) with international criteria: 0.695, 0.774, and 0.730 with the International Diabetes Federation (IDF), revised Adult Treatment Panel III, and Joint Interim Statement of the IDF criteria, respectively.

Conclusions: We recommend eliminating the 2-h PPG blood test and lowering the FPG diagnostic cut-off value to 5.6 mmol/L in the CDS-MS diagnostic criteria.

Citing Articles

Effects of high-normal fasting blood glucose on ART outcomes of frozen-thawed single blastocyst transfer in women with normal BMI.

Wang L, Tian X, Li H, Yang L, Zhou W J Assist Reprod Genet. 2024; 41(10):2615-2623.

PMID: 38970737 PMC: 11534951. DOI: 10.1007/s10815-024-03191-w.


Assessing the generalisability of the psychosis metabolic risk calculator (PsyMetRiC) for young people with first-episode psychosis with validation in a Hong Kong Chinese Han population: a 4-year follow-up study.

Tse W, Khandaker G, Zhou H, Luo H, Yan W, Siu M Lancet Reg Health West Pac. 2024; 47:101089.

PMID: 38774423 PMC: 11106539. DOI: 10.1016/j.lanwpc.2024.101089.


Effects of fasting hyperglycemia in men on pregnancy outcomes of singleton pregnant women with cryo-thawed embryo transfer.

Yang L, Tian X, Li H, Sun J, Zhou W Eur J Med Res. 2023; 28(1):613.

PMID: 38115122 PMC: 10731713. DOI: 10.1186/s40001-023-01591-9.


The Incidence of Metabolic Syndrome in People Over 40 Years Old with Normal Fasting Plasma Glucose and the Predictive Cutoff Value of Effective Fasting Plasma Glucose for Metabolic Syndrome in Guiyang.

Liu Y, Zhuang H, Han N, Yang Y, Zhang Q, Peng N Diabetes Metab Syndr Obes. 2023; 16:2979-2989.

PMID: 37786865 PMC: 10541677. DOI: 10.2147/DMSO.S425412.


Prevalence of metabolic syndrome in patients with end-stage renal disease: a systematic review and meta-analysis.

Du Q, Jiang Y, Liu Y Int Urol Nephrol. 2023; 56(3):1057-1069.

PMID: 37740847 DOI: 10.1007/s11255-023-03790-z.